Recent large genomic landscape studies have showed that TP53 and PIK3CA were the two most frequently mutated driver genes in primary breast cancer and the mutation spectrum of these four genes displayed subgroup specificity with great clinical significance in cancer classification and treatment [5, 6]. This evidence concerns the gene TP53 and cancer.